Intaglio Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.05 M
- Revenue Growth %
- Profit Growth 21.57%
- Ebitda 21.57%
- Net Worth -0.10%
- Total Assets -1.88%
About Intaglio Biotech
Intaglio Biotech Private Limited (IBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 October 2009 and has a history of 15 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹1.05 M.
Salil Kumar and Rizwan serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232DL2009PTC195092
- Company No.
195092
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2009
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Intaglio Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Salil Kumar  | Director | 01-Jun-2012 | Current |
| Rizwan | Director | 13-Mar-2020 | Current |
Financial Performance of Intaglio Biotech.
Intaglio Biotech Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 21.57% increase in profit. The company's net worth dipped by a decrease of 0.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intaglio Biotech?
In 2019, Intaglio Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gangahar Infra Private LimitedSalil Kumar is a mutual person
Charges (Loans)
₹1.05 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2011 | Punjab National Bank | ₹1.05 M | Open |
How Many Employees Work at Intaglio Biotech?
Unlock and access historical data on people associated with Intaglio Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intaglio Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intaglio Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
